International

Financial Results for the Year Ended December 31, 2023

Retrieved on: 
Tuesday, April 2, 2024
Urbanization, Growth, Environment, International, International Financial Reporting Standards, Sale, News, Bank statement, TSX, Investment, NOT, Analysis, HFP

TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Helios Fairfax Partners Corporation (TSX: HFPC.U) today announced its financial results for the year ended December 31, 2023. All dollar amounts in this news release are expressed in U.S. dollars except as otherwise noted. The financial results are derived from the annual consolidated financial statements prepared using the recognition and measurement requirements of International Financial Reporting Standards as issued by the International Accounting Standards Board (“IFRS Accounting Standards”), except as otherwise noted.

Key Points: 
  • NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
    TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Helios Fairfax Partners Corporation (TSX: HFPC.U) today announced its financial results for the year ended December 31, 2023.
  • The financial results are derived from the annual consolidated financial statements prepared using the recognition and measurement requirements of International Financial Reporting Standards as issued by the International Accounting Standards Board (“IFRS Accounting Standards”), except as otherwise noted.
  • Results for the fourth quarter also include $5.3 million of expenses offset by interest income and dividends of $2.3 million.
  • A material weakness was identified in the company’s internal control over financial reporting for the year ended December 31, 2023.

NBME Recognizes Dr. Karen Hauer with Prestigious Medical Education Research Award

Retrieved on: 
Tuesday, April 2, 2024
Medical education, Internal medicine, Education, UCSF, Communication, Learning, Science, International, Patient, Bias, Knowledge, Research, University, Doctor of Philosophy, Faculty, MD, Student, Thought, MBA, UCSF Medical Center, Habit, Stanford University, Feedback, Physician, Health, NBME, Nursing

PHILADELPHIA, April 02, 2024 (GLOBE NEWSWIRE) -- Karen Hauer, MD, PhD, was selected as the recipient of NBME’s 2024 John P. Hubbard Award in recognition of her significant contributions to the field of medical education research and assessment.

Key Points: 
  • PHILADELPHIA, April 02, 2024 (GLOBE NEWSWIRE) -- Karen Hauer, MD, PhD, was selected as the recipient of NBME’s 2024 John P. Hubbard Award in recognition of her significant contributions to the field of medical education research and assessment.
  • NBME President and CEO Peter Katsufrakis, MD, MBA, echoes her sentiments about past Hubbard Award recipients and expresses his support and admiration for Dr. Hauer and her accomplishments.
  • She is an active researcher in health professions education with a focus on competency-based medical education, workplace-based assessment, equity and coaching.
  • P. Hubbard Award recognizes individuals for their outstanding contributions to the pursuit of assessment excellence within medical education.

Astrotech to Showcase the Tracer 1000 Trace Detector at ISC West Conference

Retrieved on: 
Tuesday, April 2, 2024
Narcotic, Certification, Astrotech, Conference, Heroin, Cocaine, ETD, International, Law enforcement, NTD, Prison, European Civil Aviation Conference, Exposition, Astrotech Corporation, Airport, Mass spectrometry, ASTC, TRACER, Fentanyl, Drug

The TRACER 1000 is a high-performance laboratory instrument that is powered by the Astrotech Mass Spectrometer Technology™ (“AMS Technology”).

Key Points: 
  • The TRACER 1000 is a high-performance laboratory instrument that is powered by the Astrotech Mass Spectrometer Technology™ (“AMS Technology”).
  • Currently, the Company’s Tracer 1000 ETD is now found in multiple locations in 14 countries throughout the world.
  • “We are extremely excited to share our user-friendly mass spectrometer the TRACER 1000, which is powered by our AMS Technology, with leading industry experts and security industry professionals at the ISC West conference.
  • The TRACER 1000 is the first mass spectrometry-based ETD to have received European Civil Aviation Conference (“ECAC”) certification for both checkpoint and cargo security.

Global Uranium Production to Increase as Prices Are Expected to Hit a 15 Year High

Retrieved on: 
Tuesday, April 2, 2024
Triple, CPS, Appaloosa, International Financial Reporting Standards, Transport, OTCQX, Party, Westinghouse, Count, Technical, International, PALM, PLS, GlobalData, Fertility, Stallion, Glacier Media, Climate change, COP28, STUD, Ice, OTCQB, FCU, Athabasca Basin, News, Handgun holster, Radioactive decay, TSX, NXE, NexGen, Mining, Conference, Growth, Conference of the Parties, Fission, FUU, BGO, Uranium mining

It added: "Kazakhstan is expected to deliver the highest uranium production growth in 2024, GlobalData says, driven by the planned higher output from the country’s largest uranium producer Kazatomprom.

Key Points: 
  • It added: "Kazakhstan is expected to deliver the highest uranium production growth in 2024, GlobalData says, driven by the planned higher output from the country’s largest uranium producer Kazatomprom.
  • The continuous ramp-up of Canada’s McArthur River uranium mine will also contribute to the global increase, it adds.
  • Despite a 5.1% dip in output in 2023 due to planned lower production from Kazatomprom, its output is expected to recover in 2024, with forecast production of 23.2kt.
  • It continued: “Meanwhile, global uranium production in 2024 will be further bolstered by continuous ramp-up of Canada’s McArthur River, which is aiming to produce 6.9kt of uranium (8.2kt of U3O8) for 2024.

Getty Images Acquires Motorsport Images, a Specialist Motorsport Archive

Retrieved on: 
Tuesday, April 2, 2024
Organization, Motorsport, International, Miami Grand Prix, Getty Images, History, French Grand Prix, Getty, Formula One, UEFA, NBA, PGA Tour, NASCAR, Major League Baseball, Television

LONDON, April 02, 2024 (GLOBE NEWSWIRE) -- Getty Images (NYSE: GETY), a preeminent global visual content creator and marketplace, and Motorsport Images, a specialist motorsport archive, today announced that Getty Images has acquired Motorsport Images, including its operative arm LAT Images and its Sutton, Schlegelmilch, Colombo and Dukes Video archives.

Key Points: 
  • LONDON, April 02, 2024 (GLOBE NEWSWIRE) -- Getty Images (NYSE: GETY), a preeminent global visual content creator and marketplace, and Motorsport Images , a specialist motorsport archive, today announced that Getty Images has acquired Motorsport Images, including its operative arm LAT Images and its Sutton, Schlegelmilch, Colombo and Dukes Video archives.
  • The addition of Motorsport Images’ photographic talent and premium motorsport archive complements Getty Images’ award-winning motorsports photographers, its expert operations team and rich sports archive, augmenting Getty Images’ customer offering in the motorsport space.
  • “We are thrilled to welcome Motorsport Images to Getty Images,” said Craig Peters, Chief Executive Officer, Getty Images.
  • Their impressive archive of iconic imagery and video will expand upon our premium motorsport offering to Getty Images’ global customer base.”
    “I’m so proud of what the Motorsport Images team has built over our history and of the high-quality service and outstanding visuals we provide our customers,” said Steven Tee, Managing Director, Motorsport Images.

Identity and Access Management Software Provider BIO-key Preliminary 2023 Results: Operating Loss Trimmed Approx. $3.5M on Approx. 29% Revenue Growth to $9.1M; Investor Call Tomorrow at 10am ET

Retrieved on: 
Monday, April 1, 2024
Research, Identity management, Microsoft, Organization, MFA, Software as a service, Apple, Access management, Amazon, International, Sale, IAM, Bank statement, Traction, Cyber insurance, Workforce, Identity, Marketing, Engineering

The independent audit of BIO-key’s 2023 financial statements has not yet been completed and, therefore, the figures included herein are subject to change.

Key Points: 
  • The independent audit of BIO-key’s 2023 financial statements has not yet been completed and, therefore, the figures included herein are subject to change.
  • We look to build on this record in 2024, focusing on top-line growth opportunities balanced with further efforts to reduce costs.
  • We believe our growing global distribution and customer base puts us in a strong position to reach profitability over the next several quarters.
  • In terms of operating expenses, Selling, general and administrative costs were $7.3M in 2023, representing a 22% decrease from 2022.

SKYX Reports Record Sales of $58.8 Million for 2023 and Fourth Quarter Record Sales of $22.2 Million as it Continues to Enhance its Market Penetration for Both Retail and Pro Segments

Retrieved on: 
Monday, April 1, 2024
ALA, General Electric, Annual report, Tax, NAHB, BelAmi, Acceleration, Partnership, ANSI, International, Sale, Acquisition, National Electrical Code, Consumer Electronics Show, NEC, Investment, Safety, Depreciation, CES, IBS, Lighting, Data aggregation, Marketing, Video game

Generated a record $58.8 million in revenue in 2023, including E-commerce sales, smart home products and advanced plug & play products, as compared to $32,022 in 2022.

Key Points: 
  • Generated a record $58.8 million in revenue in 2023, including E-commerce sales, smart home products and advanced plug & play products, as compared to $32,022 in 2022.
  • Generated a record $22.2 million in revenue in the fourth quarter of 2023.
  • SKYX has started sales to the builder and pro segments and opened over 100 builder and pro accounts during the International Builders’ Show (IBS - NAHB) in Las Vegas.
  • Additionally, our e-commerce website platform continues to enhance the acceleration of marketing, distribution channels, collaborations, and sales to both professional and retail segments.

TOMI Environmental Solutions, Inc. Reports Fourth Quarter and Year End 2023 Financial Results

Retrieved on: 
Monday, April 1, 2024
Hydrogen, MGH, Health, Hydrogen peroxide, Sale, Restaurant, Ionization, RELX, International, Webcast, Education, Harvard University, Food industry, GPO, Holiday, Global Biorisk Advisory Council, Academic Medical Center (Amsterdam), Police, Meat, Completion, Transport, Decontamination, Medication, AALAS, American Biological Safety Association, Research, Hospital, Food, ISSA, BIT, CES, Disinfectant, Conference, Horsepower, Growth, Assistant, MIT, Executive, School, Infection, DARPA, Environmental Health (journal), Raymond Castellani, Health care

FREDERICK, Md., April 01, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist brand of products, today announced its fourth quarter and year end 2023 results.

Key Points: 
  • FREDERICK, Md., April 01, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist brand of products, today announced its fourth quarter and year end 2023 results.
  • Financial Results for the year ended December 31, 2023, compared to December 31, 2022
    Total net revenue was $7,355,000 compared to $8,338,000.
  • Financial Results for the three months ended December 31, 2023, compared to December 31, 2022
    Total net revenue was $1,528,000 compared to $2,812,000.
  • TOMI will hold a conference call to discuss Fourth Quarter and year end 2023 results at 4:30 p.m.

Goodness Growth Holdings Announces Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Monday, April 1, 2024
Interest, International, Goodness, Tenant, Sale, Treasury, Toll, Event, Biomass, Property management

MINNEAPOLIS, April 01, 2024 (GLOBE NEWSWIRE) -- Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), a cannabis company committed to providing safe access, quality products and great value to its customers, today reported financial results for its fourth quarter and full year ended December 31, 2023. Key financial results are presented below in summary form with supporting commentary and discussion from management of certain key operating metrics which the Company uses to judge its performance. All currency figures referenced herein are denominated in U.S. dollars.

Key Points: 
  • 2"A Flower" refers to produced biomass that meet the Company's highest internal standards for flower quality, size, and appearance.
  • As of December 31, 2023, total current assets were $148.9 million, including cash on hand of $16.0 million.
  • As of December 31, 2023, the Company had a total of 232,799,343 shares outstanding on the treasury method basis.
  • ET (3:30 p.m. CT) to discuss its financial results for its fourth quarter and full year ended December 31, 2023.

Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection

Retrieved on: 
Monday, April 1, 2024
International, Patient, Sale, Bankruptcy Code, Acquisition, United States bankruptcy court, Bankruptcy, PALO, Therapy, Sidley Austin, Eiger

PALO ALTO, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR) today announced that it and its direct subsidiaries have filed voluntary petitions for chapter 11 protection under the United States Bankruptcy Code in the United States Bankruptcy Court for the Northern District of Texas. The company also announced a “stalking horse” agreement for the sale of Zokinvy® (lonafarnib) to Sentynl Therapeutics, Inc., a biopharmaceutical company focused on rare diseases. Under the terms of the “stalking horse” agreement, subject to court approval, Sentynl Therapeutics will pay up to $26.0 million, subject to certain purchase price adjustments, including per diem reductions if the sale closes after April 24, 2024, for the acquisition of Zokinvy®. In accordance with Section 363 of the Bankruptcy Code, other potential bidders can submit competing bids for the company’s assets through a court-supervised process.  

Key Points: 
  • PALO ALTO, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR) today announced that it and its direct subsidiaries have filed voluntary petitions for chapter 11 protection under the United States Bankruptcy Code in the United States Bankruptcy Court for the Northern District of Texas.
  • Eiger filed customary “first day” motions with the court requesting relief designed to enable Eiger to transition into chapter 11 and uphold its commitments to stakeholders during the process without material disruption to its ordinary course of operations.
  • Court filings and other information regarding the chapter 11 case are available via Kurtzman Carson Consultants LLC, a third-party bankruptcy claims and noticing agent, at: www.kccllc.net/Eiger.
  • Eiger does not undertake and specifically disclaims any obligation to update any forward-looking statements, whether as a result of any new information, future events, changed circumstances or otherwise.